CSS LLC’s Aimmune Therapeutics AIMT Stock Holding History

CSS LLC’s Portfolio AIMT Stock Details AIMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-11,200	Closed	-$386K	–	1058
2020 Q3	$386K	Sell	11,200 -13,500	-55%	-$288K	0.02%	463
2020 Q2	$413K	Sell	24,700 -29,500	-54%	-$501K	0.02%	405
2020 Q1	$782K	Buy	+54,200	New	+$1.39M	0.06%	239

CSS LLC's AIMT Position: Q4 2020 in Review

CSS LLC sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 15,300 shares — an estimated $528K sold.

CSS LLC first reported a position in AIMT in Q1 2020 and held it in 3 quarters. The position peaked at $528K in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

CSS LLC reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
CSS LLC sold 15,300 Aimmune Therapeutics shares in Q4 2020, an estimated $528K.
CSS LLC first reported a position in Aimmune Therapeutics in Q1 2020 and held it in 3 quarters.
CSS LLC's Aimmune Therapeutics position peaked at $528K in Q3 2020.
0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on CSS LLC's 13F filing for Q4 2020, filed 16 Feb 2021.